The Advisory Team at Artiva Biotherapeutics provides strategic guidance and expert insights to advance the development and clinical application of NK cell and CAR-NK therapies for cancer treatment. They leverage their extensive experience to support decision-making processes, optimize therapeutic approaches, and foster partnerships within the medical and scientific communities.
View all